Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


Latest News

Date posted: 2/1/2013

Patients taking the birth control drugs Yaz or Yasmin have been warned of studies showing they may be at a higher risk of dangerous blood clots due to the hormone drospirenone. Thousands have now filed lawsuits over these injuries in the U.S. and Europe and Bayer has stepped up efforts to settle the claims in the United States.
Now, the company has been hit with more bad news out of Europe over another drug market for contraception. The drug Diane-35, also sold as Dianette, has also been linked to higher risks of blood clots and several patient deaths.*
Last month, France’s Health Ministry announced that it would stop reimbursing for third and fourth-generation birth control pills like Yaz and Yasmin over blood clot health risks. They also said they would investigate whether the drugs were being overprescribed by non-specialist physicians.**
Yaz lawsuits, which began in the United States and are now settling, have now moved into France as well.  Even more troubling for Bayer is that Switzerland’s largest health insurer, CSS, has joined in these lawsuits to recoup costs of treatment for blood clot injuries.
However, the latest warning from France’s drug safety authority over Diane-35 shows the company is facing a systemic problem over contraceptives linked to blood clots.
Although Diane-35 is designed to fight acne, it is also prescribed as a contraceptive due to its hormone makeup. Experts estimate as many as 315,000 women each year use the drug in Europe. Already, four deaths have been linked to blood clot injuries with Diane-35.
Bayer’s latest financial statements indicate the company has spent as much as $750 million to compensate victims of blood clots in the United States. While the Yaz settlements continue, experts believe they could conclude sometime in 2013.
If you or a loved one suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin, it is important to speak with a lawyer as soon as possible about your legal options.
The Drug Risk Resource Center cautions Yaz patients that they should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, contact us today.
** reuters.com/article/2013/01/03/france-contraception-idUSL5E9C31XG20130103